Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 3
2006 2
2007 6
2008 7
2009 6
2010 3
2011 8
2012 4
2013 6
2014 6
2015 7
2016 7
2017 11
2018 6
2019 9
2020 19
2021 18
2022 19
2023 15
2024 20
2025 18
2026 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

185 results

Results by year

Filters applied: . Clear all
Page 1
Real-World Outcomes of [177Lu]Lu-PSMA-617 in the French Early-Access Program for Patients with Metastatic Castration-Resistant Prostate Cancer.
Bailly C, Vija L, Somme F, Massard V, Barthélémy P, Giraudet AL, Godbert Y, Fléchon A, Girault S, Abadie-Lacourtoisie S, Viala C, Douillet A, Chêne S, Olivier P, Roubaud G. Bailly C, et al. Among authors: flechon a. J Nucl Med. 2026 Aug 6:jnumed.126.272721. doi: 10.2967/jnumed.126.272721. Online ahead of print. J Nucl Med. 2026. PMID: 42562607
Fumarate hydratase-deficient renal cell carcinoma - results of the exploratory analysis in the SUNNIFORECAST trial comparing Ipilimumab plus Nivolumab vs standard of care as first line treatment.
Ahrens M, Haanen J, Albiges L, Goupil MG, Boleti E, Gravis G, Fléchon A, Grimm MO, Bedke J, Barthélémy P, Castellano D, Mellado B, Ivanyi P, Rottey S, Flörcken A, Suárez C, Maroto JP, Grünwald V, Oosting S, Kopecky J, Zschäbitz S, Boegemann M, Buchler T, Niegisch G, Goebell PJ, Waddell T, Joly F, Priou F, Retz M, Siemer S, Zimmermann U, Deckbar D, Burkholder I, Stöhr C, Hartmann A, Bergmann L; Interdisciplinary Renal Cell Carcinoma Working Group of the DKG (IAGN). Ahrens M, et al. Among authors: flechon a. Cancer Treat Res Commun. 2026 Jul 18;48:101319. doi: 10.1016/j.ctarc.2026.101319. Online ahead of print. Cancer Treat Res Commun. 2026. PMID: 42470850 Free article.
Adjusted Comparison of First-line Enfortumab Vedotin Plus Pembrolizumab Versus Platinum-based Chemotherapy ± Avelumab Maintenance for the Treatment of Locally Advanced/Metastatic Urothelial Carcinoma.
Dillon R, Jones R, Fléchon A, Chan K, Pepper AN, McLoone D, Keeping S, Jansen JP, Thompson A, Wilson FR. Dillon R, et al. Among authors: flechon a. Eur Urol Oncol. 2026 Jun 26:S2588-9311(26)00172-0. doi: 10.1016/j.euo.2026.06.004. Online ahead of print. Eur Urol Oncol. 2026. PMID: 42362438 Free article.
Parental occupational exposure to pesticides at birth and risk of adult testicular germ cell tumours in offspring: a French nationwide case-control study.
Paul A, Danjou A, Coste A, Kromhout H, Lefevre M, Spinosi J, Dananché B, Olsson A, Lamouroux C, Guth M, Béranger R, Pérol O, Boyle H, Hersant C, Loup-Cabaniols V, Veau S, Perrin J, Schüz J, Charbotel B, Fervers B; TESTIS study group. Paul A, et al. Occup Environ Med. 2026 Jul 22;83(4):195-203. doi: 10.1136/oemed-2024-109893. Occup Environ Med. 2026. PMID: 42331594 Free article.
Papillary renal cell carcinoma - exploratory results of the SUNNIFORECAST trial comparing Ipilimumab plus Nivolumab vs standard of care as first line therapy based on central pathological review.
Ahrens M, Haanen J, Albiges L, Goupil MG, Boleti E, Gravis G, Fléchon A, Grimm MO, Bedke J, Barthélémy P, Castellano D, Mellado B, Ivanyi P, Rottey S, Flörcken A, Suárez C, Maroto JP, Grünwald V, Oosting S, Kopecky J, Zschäbitz S, Boegemann M, Buchler T, Niegisch G, Goebell PJ, Waddell T, Joly F, Priou F, Retz M, Siemer S, Zimmermann U, Deckbar D, Burkholder I, Hartmann A, Bergmann L; Interdisciplinary Renal Cell Carcinoma Working Group of the DKG (IAGN). Ahrens M, et al. Among authors: flechon a. Eur J Cancer. 2026 Jul 26;243:116816. doi: 10.1016/j.ejca.2026.116816. Epub 2026 May 27. Eur J Cancer. 2026. PMID: 42235464 Free article. Clinical Trial.
Neoadjuvant Durvalumab ± Tremelimumab in Combination With Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Muscle-Invasive Bladder Carcinoma: Results of the Phase I/II NEMIO Study.
Thibault C, Bennamoun M, Fléchon A, Gravis G, Pouessel D, Combe P, Borchiellini D, Loriot Y, Laguerre B, Barthélémy P, Huillard O, Gross-Goupil M, Le Roy A, Jaffrelot L, Cancel M, Audenet F, Belhouari H, Kaci G, Lepicard E, Vernerey D, Henriques J, Oudard S. Thibault C, et al. Among authors: flechon a. J Clin Oncol. 2026 Jul 10;44(20):1921-1932. doi: 10.1200/JCO-25-03045. Epub 2026 May 26. J Clin Oncol. 2026. PMID: 42190158 Clinical Trial.
Real-world efficacy and safety of immune checkpoint blockades in advanced urothelial carcinoma with histologic variant subtypes: the pembroblad study.
Amrane K, Campedel L, Moinard-Butot F, Gout M, Mahammedi H, Bennamoun M, Herrmann T, Gabriel PE, Pouessel D, Roulleaux-Dugage M, Thibault C, Cancel M, Flechon A, Huillard O, Abbar B, Borchiellini D, Doublet L, Augusto-Pelegrin L, Boughalem E, Cornillon P, Dumont C, Barthélémy P. Amrane K, et al. Among authors: flechon a. Cancer Immunol Immunother. 2026 May 24;75(8):191. doi: 10.1007/s00262-026-04421-z. Cancer Immunol Immunother. 2026. PMID: 42177701 Free PMC article. Review.
Residence Near Agricultural Crops at Birth and Risk of Adult Testicular Germ Cell Tumors: A French Nationwide Case-Control Study Using Historical Aerial GIS Data.
Danjou AMN, Coste A, Grassot L, Faure E, Crispim-Junior C, Tougne Rodet L, Pérol O, Béranger R, Perrin J, Charbotel B, Schüz J, Fervers B; TESTIS study group. Danjou AMN, et al. Int J Cancer. 2026 Sep 1;159(5):1153-1166. doi: 10.1002/ijc.70469. Epub 2026 May 18. Int J Cancer. 2026. PMID: 42152549 Free PMC article.
Phase II study of magrolimab combined with docetaxel in previously treated metastatic advanced solid tumors.
Italiano A, García Manrique T, Grande Pulido E, Kerrigan K, Fléchon A, Martínez Pérez J, Żurawski B, Furqan M, Juan-Vidal O, Vaishampayan U, Fares C, Fang B, Vicuna B, Greillier L, Subbiah V, Dong M, Song K, Zhang Y, Kim Y, Paz-Ares L. Italiano A, et al. Among authors: flechon a. Front Oncol. 2026 Apr 22;16:1786385. doi: 10.3389/fonc.2026.1786385. eCollection 2026. Front Oncol. 2026. PMID: 42100424 Free PMC article.
Cabozantinib in patients with non-locally pretreated brain metastases from renal cell carcinoma: Results of the multicenter phase II trial CABRAMET.
Negrier S, Mourey L, Dalban C, Gross-Goupil M, Fléchon A, Escudier B, Barthélémy P, Oudard S, Colomba E, Thibault C, Ravaud A, Chevreau C, Boyle HJ, Blanc E, Chabaud S, Pérol D, Albiges L, Flippot R; Groupe d’Etude des Tumeurs UroGénitale (Urogenital Tumor Study Group, GETUG) investigators. Negrier S, et al. Among authors: flechon a. Eur J Cancer. 2026 May 15;239:116712. doi: 10.1016/j.ejca.2026.116712. Epub 2026 Apr 1. Eur J Cancer. 2026. PMID: 41946178 Clinical Trial.
185 results